Related references
Note: Only part of the references are listed.Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer
Jae-Heon Jeong et al.
INVESTIGATIONAL NEW DRUGS (2012)
Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer
Ali I. Shamseddine et al.
CHEMOTHERAPY (2011)
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
Claudette E. Loo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer
H. Jinno et al.
ANNALS OF ONCOLOGY (2010)
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
Jorma J. de Ronde et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
Miguel Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Prospective Study of Vinorelbine and Capecitabine Combination Therapy in Chinese Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
Ying Fan et al.
CHEMOTHERAPY (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Comparative validation of the SP6 antibody to Ki67 in breast cancer
Lila Zabaglo et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy
Silvia Darb-Esfahani et al.
BREAST CANCER RESEARCH (2009)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
Priya Rastogi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer:: Phase III randomized GeparTrio trial
Gunter von Minckwitz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy
M. Colleoni et al.
ANNALS OF ONCOLOGY (2008)
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival
Masakazu Toi et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
M. Kaufmann et al.
ANNALS OF ONCOLOGY (2007)
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer:: Comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility
William C. Powell et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: An update of the initial randomized study population and data of additional patients treated with the same regimen
Aman U. Buzdar et al.
CLINICAL CANCER RESEARCH (2007)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques
CM Ellis et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular classification of breast carcinomas using tissue microarrays
G Callagy et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2003)
Share Paper
